SG3 Management’s Labcorp LH Stock Holding History

SG3 Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,933	Closed	-$664K	–	634
2022 Q1	$664K	Buy	+2,933	New	+$690K	0.02%	543

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SG3 Management's LH Position: Q2 2022 in Review

SG3 Management sold out of Labcorp (LH) in Q2 2022, closing a stake of 2,933 shares — an estimated $664K sold.

SG3 Management first reported a position in LH in Q1 2022 and held it in 1 quarter. The position peaked at $664K in Q1 2022. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

SG3 Management reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 2,933 Labcorp shares in Q2 2022, an estimated $664K.
SG3 Management first reported a position in Labcorp in Q1 2022 and held it in 1 quarter.
SG3 Management's Labcorp position peaked at $664K in Q1 2022.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.